Bayer to Increase Pharmaceutical R&D Spend

Bayer have announced additional details on the future of their pharmaceutical research and development business following the announcement earlier this week that they will be concentrating on their healthcare and crop science businesses going forward. The announcement confirmed Bayer plans to float their material science division on the stock market and focus on life sciences,

Continue Reading

Bayer Withdraws Schiff Bidding Interest

Bayer have declared that they are not going to follow plans to purchase American vitamins company, Schiff Nutrition International, four days after their $1.20 billion offer was beaten by Reckitt Benckiser. Roughly three weeks ago, Bayer announced a bid of $34 per share to acquire Schiff, but Reckitt since revealed an offer of $42.00 per

Continue Reading